FindTrial
Sign In

Vonoprazan 20 mg tablets ,Vocinti 20 mg

2 trials

Sponsors

Bio-innova Co., Ltd.

Conditions

Healthy volunteers, A Bioequivalence safety study Bioequivalence Vonoprazan 20 mg tabletsThe study is conducted in healthy Thai human volunteers to healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis Bioequivalence Vonoprazan 20 mg tablets

Phase 1

A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of generic Vonoprazan 20 mg tablets relative to Vocinti 20 mg, in healthy Thai participants under fasting condition
Active, not recruitingTCTR20250827016
Bio-innova Co., Ltd.The study is conducted in healthy Thai human volunteers to healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis Bioequivalence Vonoprazan 20 mg tablets
Start: 2025-12-16Target: 36Updated: 2026-08-03
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of generic Vonoprazan 20 mg tablets relative to Vocinti 20 mg, in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20251127001
Bio-innova Co., Ltd.Healthy volunteers, A Bioequivalence safety study Bioequivalence Vonoprazan 20 mg tablets
Start: 2025-12-16Target: 30Updated: 2026-08-03